Journal: Redox Biology
Article Title: Inhibition of S100A8/A9 ameliorates neuroinflammation by blocking NET formation following traumatic brain injury ☆
doi: 10.1016/j.redox.2025.103532
Figure Lengend Snippet: PAD4 deficiency abolished the effects of S100A8/A9 on neurological functions and inflammatory/apoptotic protein levels after TBI . A Quantitative analysis of DNA in the supernatant from neutrophils in vitro treated with S100A8/A9. ∗∗p < 0.01, ∗∗∗p < 0.001, n = 6 per group. B, C Representative immunofluorescence staining NETs (H3cit, green) (B) and quantitative analyses of H3cit-positive cells (C) in neutrophils in vitro. Nuclei were stained with DAPI (blue). Scale bar = 50 μm ∗∗∗p < 0.001, n = 6 per group. D, E Representative immunofluorescence staining (D) of DCFH-DA (green) and quantitative analyses of fluorescence intensity of DCFH-DA (E) in neutrophils in vitro. Scale bar = 50 μm ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, n = 6 per group. F Quantitative analyses of plasma DNA at 3 d after TBI. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, n = 6 per group. G, H mNSS test (G) and Rotarod test (H) at 3 d post-TBI. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, n = 8 per group. I–K pro-inflammation-associated mRNA levels were evaluated including CD86 (I) , IL-1β (J) , and IL-6 (K) . ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, n = 8 per group. L, M anti-inflammation-associated mRNA levels were evaluated including CD206 (L) and Arginase-1 (M) . ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, n = 8 per group. N Representative image of the FJC (green) staining in the cortex at 3 d after TBI. Nuclei were stained with DAPI (blue). Scale bar = 50 μm. O Quantitative analyses of FJC-positive cells in the peri-contusional cortex at 3 d after TBI. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, n = 6 per group.
Article Snippet: Recombinant PAD4 adenovirus (Ad-PAD4; Adeno-CMV-Padi4-3∗flag-tagged SV40-EGFP, 4 × 10 10 plaque-forming-unit/mL) and control adenovirus (Ad-con, Adeno-CMV-3∗flag-tagged SV40-EGFP) were purchased from Genechem (Shanghai, China).
Techniques: In Vitro, Immunofluorescence, Staining, Fluorescence, Clinical Proteomics